Walgreens Boots Alliance | WBA


Peers Price Chg Day Year Date
Acadia Healthcare 16.77 0.88 5.54% -59.16% Feb/13
Align Technology 186.77 2.91 1.58% -9.67% Feb/13
Elevance Health 346.80 10.76 3.20% -10.91% Feb/13
Option Care Health 35.42 0.99 2.88% 12.59% Feb/13
Brookdale Senior Living 16.51 0.20 1.20% 210.83% Feb/13
Cardinal Health 220.79 5.73 2.66% 74.94% Feb/13
Cigna 291.44 3.83 1.33% -0.30% Feb/13
Centene 40.58 1.40 3.57% -28.63% Feb/13
Charles River Laboratories 161.35 2.61 1.64% 6.16% Feb/13
CVS Health 78.48 0.55 0.71% 19.22% Feb/13

Indexes Price Day Year Date
USND 22547 -50.48 -0.22% 12.58% Feb/13

Walgreens Boots Alliance traded at $11.98 this Wednesday August 27th, increasing $0.06 or 0.50 percent since the previous trading session. Looking back, over the last four weeks, Walgreens Boots Alliance gained 3.01 percent. Over the last 12 months, its price rose by 27.79 percent. Looking ahead, we forecast Walgreens Boots Alliance to be priced at 11.61 by the end of this quarter and at 10.58 in one year, according to Trading Economics global macro models projections and analysts expectations.

Walgreens Boots Alliance, Inc. is a holding company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of equity method investment in AmerisourceBergen. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots, as well as global health and beauty product brands, including No7, NICE!, Soap & Glory, Liz Earle, Finest Nutrition, Botanics, Well Beginnings, Sleek MakeUP and YourGoodSkin.